Durkin Bryan T's Form 4 filing
CME Group Inc. (CME) · filed Sep 3, 2024
- Accession no.
- 0001156375-24-000154
- Filed
- Sep 3, 2024
- Trade date
- Aug 30-Sep 3, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.63M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Durkin Bryan TCIK 0001341363 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 | Common Stock Class A | SSaleDisposed | −7,593 | $214.59F1 | −$1,629,381.87 | 55,607 | Direct | |
| Sep 3, 2024 | Common Stock Class A | GGiftDisposed | −465 | $0.00 | $0 | 55,142 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in column four is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.29 to $214.82. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, with full information regarding the number of shares sold at each separate price within this above range.
Referenced by the price of 1 transaction in Table I.